Intuitive Surgical Gets European Marketing Approval; Shares Up More Than 2%

Intuitive Surgical ISRG shares rose nearly three percent after the company obtained European marketing approval for its lead product.

Its recently launched da Vinci Xi Surgical System received the CE mark, enabling sales in Europe go to forward. It was cleared in April by the U.S. Food and Drug Administration.
Intuitive said it is seeking additional marketing clearances for the minimally invasive device and its components.

Earlier in June, Intuitive Surgical obtained FDA approval to market its EndoWrist One Vessel Sealer instrument for the da Vinci Xi System.

Intuitive traded recently at $422.36, up 2.8 percent.